Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 38 Wareham St, Boston,massachusetts 02118,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.sensorium.bio/
- HQ
- Boston, Massachusetts
Sensorium Therapeutics Questions
Sensorium Therapeutics's website is https://www.sensorium.bio/
Sensorium Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sensorium-therapeutics
Sensorium Therapeutics has
26 employees.
View email and phone details for 26
employees at Sensorium Therapeutics.
Sensorium Therapeutics's industry is
Biotechnology Research
Sensorium Therapeutics's top competitors are
Delix Therapeutics,
Gilgamesh Pharmaceuticals,
Atai Life Sciences,
Cybin Inc,
Compass Pathways,
Eikonizo Therapeutics,
Mindmed,
Lykos Therapeutics,
Psy Therapeutics,
Tactogen.
Sensorium Therapeutics's categories are Biotechnology Research
Sensorium Therapeutics's founding year is 2021
